FDA Inspection 1327640 — Mipharm S.p.A.
The FDA completed an inspection of Mipharm S.p.A. on February 29, 2024 in Milan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 29, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Milan (Italy)
Additional Details
Mutual Recognition Agreement (MRA)